SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ALEMBIC PHARMACEUTICALS

BSE: 533573 28 Jun 2025
Healthcare
₹ 937.8
ALEMBIC PHARMACEUTICALS LIMITED specializes in Pharmaceuticals within the Healthcare sector.

ALEMBIC PHARMACEUTICALS - Share Price & Details

Market Cap
₹19,045
High /Low
1,304 / 725.0
Stock P/E
33.5
Book Value
₹264.0
Dividend Yield
1.14
ROCE
13.0
ROE
₹11.4
Face Value
2.0
PEG Ratio
-4.54
EVEBITDA
₹19.3
Debt
1,258
CMP / FCF
188.0
Debt to equity
₹0.24
NP Ann
582
High price all time
1,304
Piotroski score
₹5.0
Graham Number
420.0
No. Eq. Shares
19.7
Net CF
₹-36.7
Net profit
582
Price to book value
3.67
Interest Coverage
₹9.76
Low price all time
31.0
Industry PE
32.7
Reserves
₹5,152
Free Cash Flow
₹-466

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
ALEMBIC PHARMACEUTICALS LTD.15838.5753.415706.43.8319,04533.5
JUBILANT PHARMOVA LIMITED2352.0136.02173.00.861870033.7
NEULAND LABORATORIES LTD.3358.24277.343283.621.621571077.5

Peer Comparison Chart


About ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS LIMITED, with Security Code 533573, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Alembic Pharma Shares Slump 2% on 4 Observations

(05 Jun 2025)
Shares of Alembic Pharmaceuticals Ltd plummeted roughly 2% in early trading on 2 June after the company got four observations from the...
Read more →

Alembic Pharma Shares Rose 2% on USFDA Nod

(29 May 2025)
Shares of Alembic Pharma Ltd rose 2% on 30 May after it announced receiving final approval from the USFDA for its blood cancer drug.
Read more →

Alembic Pharmaceuticals announces USFDA final approval for Amlodipine and Atorvastatin Tablets USP

(24 May 2025)
Amlodipine and Atorvastatin tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin.
Read more →

Alembic Pharma bags USFDA nod for high BP traetment drug

(24 May 2025)
Vadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for Amlodipine and...
Read more →

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP

(24 May 2025)
Alembic Pharmaceuticals Ltd has received final approval from the USFDA for its ANDA Amlodipine and Atorvastatin Tablets USP, 2.5 mg/10 mg,...
Read more →

Alembic Pharmaceuticals receives USFDA final approval for Rivaroxaban Tablets USP

(19 May 2025)
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for...
Read more →